Clinical Trials
2 trialsNCT02253316 2025-11-10
Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
Washington University School of Medicine
Phase 2 Active not recruiting
NCT03119883 2024-08-09
Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma
Mayo Clinic
Phase NA Completed